Global Eftrenonacog Alfa Market Growth 2022-2028
Eftrenonacog alfa is a long-acting recombinant fusion protein used in the treatment of hemophilia B. It is comprised of a single molecule of human factor IX (FIX) covalently linked to the constant region (Fc) domain of human IgG1 via recombinant DNA technology in a human embryonic kidney cell line (HEK293H) 1. The presence of the Fc domain extends the terminal half-life which confers clinical benefits of prolonged therapeutic efficacy, less frequent intravenous injections for patient convenience and improved adherence to prophylaxis.
The global market for Eftrenonacog Alfa is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Eftrenonacog Alfa market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Eftrenonacog Alfa market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Eftrenonacog Alfa market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Eftrenonacog Alfa market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Eftrenonacog Alfa players cover Vetter Pharma-Fertigung GmbH & Co.KG, Sanofi Aventis, Bioverativ Therapeutics Inc., Biogen Inc and SWEDISH ORPHAN BIOVITRUM AB. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Eftrenonacog Alfa market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Eftrenonacog Alfa market, with both quantitative and qualitative data, to help readers understand how the Eftrenonacog Alfa market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Eftrenonacog Alfa market and forecasts the market size by Type (250IU, 500IU and 1000IU), by Application (Hemophilia, Surgical Bleeding and Long-term Bleeding Prevention,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
250IU
500IU
1000IU
2000IU
Segmentation by application
Hemophilia
Surgical Bleeding
Long-term Bleeding Prevention
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Vetter Pharma-Fertigung GmbH & Co.KG
Sanofi Aventis
Bioverativ Therapeutics Inc.
Biogen Inc
SWEDISH ORPHAN BIOVITRUM AB
Chapter Introduction
Chapter 1: Scope of Eftrenonacog Alfa, Research Methodology, etc.
Chapter 2: Executive Summary, global Eftrenonacog Alfa market size (sales and revenue) and CAGR, Eftrenonacog Alfa market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Eftrenonacog Alfa sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Eftrenonacog Alfa sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Eftrenonacog Alfa market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Vetter Pharma-Fertigung GmbH & Co.KG, Sanofi Aventis, Bioverativ Therapeutics Inc., Biogen Inc and SWEDISH ORPHAN BIOVITRUM AB, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eftrenonacog Alfa Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Eftrenonacog Alfa by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Eftrenonacog Alfa by Country/Region, 2017, 2022 & 2028
2.2 Eftrenonacog Alfa Segment by Type
2.2.1 250IU
2.2.2 500IU
2.2.3 1000IU
2.2.4 2000IU
2.3 Eftrenonacog Alfa Sales by Type
2.3.1 Global Eftrenonacog Alfa Sales Market Share by Type (2017-2022)
2.3.2 Global Eftrenonacog Alfa Revenue and Market Share by Type (2017-2022)
2.3.3 Global Eftrenonacog Alfa Sale Price by Type (2017-2022)
2.4 Eftrenonacog Alfa Segment by Application
2.4.1 Hemophilia
2.4.2 Surgical Bleeding
2.4.3 Long-term Bleeding Prevention
2.5 Eftrenonacog Alfa Sales by Application
2.5.1 Global Eftrenonacog Alfa Sale Market Share by Application (2017-2022)
2.5.2 Global Eftrenonacog Alfa Revenue and Market Share by Application (2017-2022)
2.5.3 Global Eftrenonacog Alfa Sale Price by Application (2017-2022)
3 Global Eftrenonacog Alfa by Company
3.1 Global Eftrenonacog Alfa Breakdown Data by Company
3.1.1 Global Eftrenonacog Alfa Annual Sales by Company (2020-2022)
3.1.2 Global Eftrenonacog Alfa Sales Market Share by Company (2020-2022)
3.2 Global Eftrenonacog Alfa Annual Revenue by Company (2020-2022)
3.2.1 Global Eftrenonacog Alfa Revenue by Company (2020-2022)
3.2.2 Global Eftrenonacog Alfa Revenue Market Share by Company (2020-2022)
3.3 Global Eftrenonacog Alfa Sale Price by Company
3.4 Key Manufacturers Eftrenonacog Alfa Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eftrenonacog Alfa Product Location Distribution
3.4.2 Players Eftrenonacog Alfa Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Eftrenonacog Alfa by Geographic Region
4.1 World Historic Eftrenonacog Alfa Market Size by Geographic Region (2017-2022)
4.1.1 Global Eftrenonacog Alfa Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Eftrenonacog Alfa Annual Revenue by Geographic Region
4.2 World Historic Eftrenonacog Alfa Market Size by Country/Region (2017-2022)
4.2.1 Global Eftrenonacog Alfa Annual Sales by Country/Region (2017-2022)
4.2.2 Global Eftrenonacog Alfa Annual Revenue by Country/Region
4.3 Americas Eftrenonacog Alfa Sales Growth
4.4 APAC Eftrenonacog Alfa Sales Growth
4.5 Europe Eftrenonacog Alfa Sales Growth
4.6 Middle East & Africa Eftrenonacog Alfa Sales Growth
5 Americas
5.1 Americas Eftrenonacog Alfa Sales by Country
5.1.1 Americas Eftrenonacog Alfa Sales by Country (2017-2022)
5.1.2 Americas Eftrenonacog Alfa Revenue by Country (2017-2022)
5.2 Americas Eftrenonacog Alfa Sales by Type
5.3 Americas Eftrenonacog Alfa Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eftrenonacog Alfa Sales by Region
6.1.1 APAC Eftrenonacog Alfa Sales by Region (2017-2022)
6.1.2 APAC Eftrenonacog Alfa Revenue by Region (2017-2022)
6.2 APAC Eftrenonacog Alfa Sales by Type
6.3 APAC Eftrenonacog Alfa Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Eftrenonacog Alfa by Country
7.1.1 Europe Eftrenonacog Alfa Sales by Country (2017-2022)
7.1.2 Europe Eftrenonacog Alfa Revenue by Country (2017-2022)
7.2 Europe Eftrenonacog Alfa Sales by Type
7.3 Europe Eftrenonacog Alfa Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Eftrenonacog Alfa by Country
8.1.1 Middle East & Africa Eftrenonacog Alfa Sales by Country (2017-2022)
8.1.2 Middle East & Africa Eftrenonacog Alfa Revenue by Country (2017-2022)
8.2 Middle East & Africa Eftrenonacog Alfa Sales by Type
8.3 Middle East & Africa Eftrenonacog Alfa Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eftrenonacog Alfa
10.3 Manufacturing Process Analysis of Eftrenonacog Alfa
10.4 Industry Chain Structure of Eftrenonacog Alfa
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eftrenonacog Alfa Distributors
11.3 Eftrenonacog Alfa Customer
12 World Forecast Review for Eftrenonacog Alfa by Geographic Region
12.1 Global Eftrenonacog Alfa Market Size Forecast by Region
12.1.1 Global Eftrenonacog Alfa Forecast by Region (2023-2028)
12.1.2 Global Eftrenonacog Alfa Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Eftrenonacog Alfa Forecast by Type
12.7 Global Eftrenonacog Alfa Forecast by Application
13 Key Players Analysis
13.1 Vetter Pharma-Fertigung GmbH & Co.KG
13.1.1 Vetter Pharma-Fertigung GmbH & Co.KG Company Information
13.1.2 Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Product Offered
13.1.3 Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Vetter Pharma-Fertigung GmbH & Co.KG Main Business Overview
13.1.5 Vetter Pharma-Fertigung GmbH & Co.KG Latest Developments
13.2 Sanofi Aventis
13.2.1 Sanofi Aventis Company Information
13.2.2 Sanofi Aventis Eftrenonacog Alfa Product Offered
13.2.3 Sanofi Aventis Eftrenonacog Alfa Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Aventis Main Business Overview
13.2.5 Sanofi Aventis Latest Developments
13.3 Bioverativ Therapeutics Inc.
13.3.1 Bioverativ Therapeutics Inc. Company Information
13.3.2 Bioverativ Therapeutics Inc. Eftrenonacog Alfa Product Offered
13.3.3 Bioverativ Therapeutics Inc. Eftrenonacog Alfa Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bioverativ Therapeutics Inc. Main Business Overview
13.3.5 Bioverativ Therapeutics Inc. Latest Developments
13.4 Biogen Inc
13.4.1 Biogen Inc Company Information
13.4.2 Biogen Inc Eftrenonacog Alfa Product Offered
13.4.3 Biogen Inc Eftrenonacog Alfa Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Biogen Inc Main Business Overview
13.4.5 Biogen Inc Latest Developments
13.5 SWEDISH ORPHAN BIOVITRUM AB
13.5.1 SWEDISH ORPHAN BIOVITRUM AB Company Information
13.5.2 SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Product Offered
13.5.3 SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 SWEDISH ORPHAN BIOVITRUM AB Main Business Overview
13.5.5 SWEDISH ORPHAN BIOVITRUM AB Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Eftrenonacog Alfa Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Eftrenonacog Alfa Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 250IU
Table 4. Major Players of 500IU
Table 5. Major Players of 1000IU
Table 6. Major Players of 2000IU
Table 7. Global Eftrenonacog Alfa Sales by Type (2017-2022) & (K Units)
Table 8. Global Eftrenonacog Alfa Sales Market Share by Type (2017-2022)
Table 9. Global Eftrenonacog Alfa Revenue by Type (2017-2022) & ($ million)
Table 10. Global Eftrenonacog Alfa Revenue Market Share by Type (2017-2022)
Table 11. Global Eftrenonacog Alfa Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Eftrenonacog Alfa Sales by Application (2017-2022) & (K Units)
Table 13. Global Eftrenonacog Alfa Sales Market Share by Application (2017-2022)
Table 14. Global Eftrenonacog Alfa Revenue by Application (2017-2022)
Table 15. Global Eftrenonacog Alfa Revenue Market Share by Application (2017-2022)
Table 16. Global Eftrenonacog Alfa Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Eftrenonacog Alfa Sales by Company (2020-2022) & (K Units)
Table 18. Global Eftrenonacog Alfa Sales Market Share by Company (2020-2022)
Table 19. Global Eftrenonacog Alfa Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Eftrenonacog Alfa Revenue Market Share by Company (2020-2022)
Table 21. Global Eftrenonacog Alfa Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Eftrenonacog Alfa Producing Area Distribution and Sales Area
Table 23. Players Eftrenonacog Alfa Products Offered
Table 24. Eftrenonacog Alfa Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Eftrenonacog Alfa Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Eftrenonacog Alfa Sales Market Share Geographic Region (2017-2022)
Table 29. Global Eftrenonacog Alfa Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Eftrenonacog Alfa Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Eftrenonacog Alfa Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Eftrenonacog Alfa Sales Market Share by Country/Region (2017-2022)
Table 33. Global Eftrenonacog Alfa Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Eftrenonacog Alfa Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Eftrenonacog Alfa Sales by Country (2017-2022) & (K Units)
Table 36. Americas Eftrenonacog Alfa Sales Market Share by Country (2017-2022)
Table 37. Americas Eftrenonacog Alfa Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Eftrenonacog Alfa Revenue Market Share by Country (2017-2022)
Table 39. Americas Eftrenonacog Alfa Sales by Type (2017-2022) & (K Units)
Table 40. Americas Eftrenonacog Alfa Sales Market Share by Type (2017-2022)
Table 41. Americas Eftrenonacog Alfa Sales by Application (2017-2022) & (K Units)
Table 42. Americas Eftrenonacog Alfa Sales Market Share by Application (2017-2022)
Table 43. APAC Eftrenonacog Alfa Sales by Region (2017-2022) & (K Units)
Table 44. APAC Eftrenonacog Alfa Sales Market Share by Region (2017-2022)
Table 45. APAC Eftrenonacog Alfa Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Eftrenonacog Alfa Revenue Market Share by Region (2017-2022)
Table 47. APAC Eftrenonacog Alfa Sales by Type (2017-2022) & (K Units)
Table 48. APAC Eftrenonacog Alfa Sales Market Share by Type (2017-2022)
Table 49. APAC Eftrenonacog Alfa Sales by Application (2017-2022) & (K Units)
Table 50. APAC Eftrenonacog Alfa Sales Market Share by Application (2017-2022)
Table 51. Europe Eftrenonacog Alfa Sales by Country (2017-2022) & (K Units)
Table 52. Europe Eftrenonacog Alfa Sales Market Share by Country (2017-2022)
Table 53. Europe Eftrenonacog Alfa Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Eftrenonacog Alfa Revenue Market Share by Country (2017-2022)
Table 55. Europe Eftrenonacog Alfa Sales by Type (2017-2022) & (K Units)
Table 56. Europe Eftrenonacog Alfa Sales Market Share by Type (2017-2022)
Table 57. Europe Eftrenonacog Alfa Sales by Application (2017-2022) & (K Units)
Table 58. Europe Eftrenonacog Alfa Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Eftrenonacog Alfa Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Eftrenonacog Alfa Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Eftrenonacog Alfa Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Eftrenonacog Alfa Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Eftrenonacog Alfa Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Eftrenonacog Alfa Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Eftrenonacog Alfa Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Eftrenonacog Alfa Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Eftrenonacog Alfa
Table 68. Key Market Challenges & Risks of Eftrenonacog Alfa
Table 69. Key Industry Trends of Eftrenonacog Alfa
Table 70. Eftrenonacog Alfa Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Eftrenonacog Alfa Distributors List
Table 73. Eftrenonacog Alfa Customer List
Table 74. Global Eftrenonacog Alfa Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Eftrenonacog Alfa Sales Market Forecast by Region
Table 76. Global Eftrenonacog Alfa Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Eftrenonacog Alfa Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Eftrenonacog Alfa Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Eftrenonacog Alfa Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Eftrenonacog Alfa Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Eftrenonacog Alfa Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Eftrenonacog Alfa Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Eftrenonacog Alfa Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Eftrenonacog Alfa Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Eftrenonacog Alfa Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Eftrenonacog Alfa Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Eftrenonacog Alfa Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Eftrenonacog Alfa Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Eftrenonacog Alfa Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Eftrenonacog Alfa Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Eftrenonacog Alfa Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Eftrenonacog Alfa Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Eftrenonacog Alfa Revenue Market Share Forecast by Application (2023-2028)
Table 94. Vetter Pharma-Fertigung GmbH & Co.KG Basic Information, Eftrenonacog Alfa Manufacturing Base, Sales Area and Its Competitors
Table 95. Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Product Offered
Table 96. Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Vetter Pharma-Fertigung GmbH & Co.KG Main Business
Table 98. Vetter Pharma-Fertigung GmbH & Co.KG Latest Developments
Table 99. Sanofi Aventis Basic Information, Eftrenonacog Alfa Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Aventis Eftrenonacog Alfa Product Offered
Table 101. Sanofi Aventis Eftrenonacog Alfa Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Sanofi Aventis Main Business
Table 103. Sanofi Aventis Latest Developments
Table 104. Bioverativ Therapeutics Inc. Basic Information, Eftrenonacog Alfa Manufacturing Base, Sales Area and Its Competitors
Table 105. Bioverativ Therapeutics Inc. Eftrenonacog Alfa Product Offered
Table 106. Bioverativ Therapeutics Inc. Eftrenonacog Alfa Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Bioverativ Therapeutics Inc. Main Business
Table 108. Bioverativ Therapeutics Inc. Latest Developments
Table 109. Biogen Inc Basic Information, Eftrenonacog Alfa Manufacturing Base, Sales Area and Its Competitors
Table 110. Biogen Inc Eftrenonacog Alfa Product Offered
Table 111. Biogen Inc Eftrenonacog Alfa Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Biogen Inc Main Business
Table 113. Biogen Inc Latest Developments
Table 114. SWEDISH ORPHAN BIOVITRUM AB Basic Information, Eftrenonacog Alfa Manufacturing Base, Sales Area and Its Competitors
Table 115. SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Product Offered
Table 116. SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. SWEDISH ORPHAN BIOVITRUM AB Main Business
Table 118. SWEDISH ORPHAN BIOVITRUM AB Latest Developments
List of Figures
Figure 1. Picture of Eftrenonacog Alfa
Figure 2. Eftrenonacog Alfa Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eftrenonacog Alfa Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Eftrenonacog Alfa Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Eftrenonacog Alfa Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 250IU
Figure 10. Product Picture of 500IU
Figure 11. Product Picture of 1000IU
Figure 12. Product Picture of 2000IU
Figure 13. Global Eftrenonacog Alfa Sales Market Share by Type in 2021
Figure 14. Global Eftrenonacog Alfa Revenue Market Share by Type (2017-2022)
Figure 15. Eftrenonacog Alfa Consumed in Hemophilia
Figure 16. Global Eftrenonacog Alfa Market: Hemophilia (2017-2022) & (K Units)
Figure 17. Eftrenonacog Alfa Consumed in Surgical Bleeding
Figure 18. Global Eftrenonacog Alfa Market: Surgical Bleeding (2017-2022) & (K Units)
Figure 19. Eftrenonacog Alfa Consumed in Long-term Bleeding Prevention
Figure 20. Global Eftrenonacog Alfa Market: Long-term Bleeding Prevention (2017-2022) & (K Units)
Figure 21. Global Eftrenonacog Alfa Sales Market Share by Application (2017-2022)
Figure 22. Global Eftrenonacog Alfa Revenue Market Share by Application in 2021
Figure 23. Eftrenonacog Alfa Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Eftrenonacog Alfa Revenue Market Share by Company in 2021
Figure 25. Global Eftrenonacog Alfa Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Eftrenonacog Alfa Revenue Market Share by Geographic Region in 2021
Figure 27. Global Eftrenonacog Alfa Sales Market Share by Region (2017-2022)
Figure 28. Global Eftrenonacog Alfa Revenue Market Share by Country/Region in 2021
Figure 29. Americas Eftrenonacog Alfa Sales 2017-2022 (K Units)
Figure 30. Americas Eftrenonacog Alfa Revenue 2017-2022 ($ Millions)
Figure 31. APAC Eftrenonacog Alfa Sales 2017-2022 (K Units)
Figure 32. APAC Eftrenonacog Alfa Revenue 2017-2022 ($ Millions)
Figure 33. Europe Eftrenonacog Alfa Sales 2017-2022 (K Units)
Figure 34. Europe Eftrenonacog Alfa Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Eftrenonacog Alfa Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Eftrenonacog Alfa Revenue 2017-2022 ($ Millions)
Figure 37. Americas Eftrenonacog Alfa Sales Market Share by Country in 2021
Figure 38. Americas Eftrenonacog Alfa Revenue Market Share by Country in 2021
Figure 39. United States Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Eftrenonacog Alfa Sales Market Share by Region in 2021
Figure 44. APAC Eftrenonacog Alfa Revenue Market Share by Regions in 2021
Figure 45. China Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Eftrenonacog Alfa Sales Market Share by Country in 2021
Figure 52. Europe Eftrenonacog Alfa Revenue Market Share by Country in 2021
Figure 53. Germany Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Eftrenonacog Alfa Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Eftrenonacog Alfa Revenue Market Share by Country in 2021
Figure 60. Egypt Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Eftrenonacog Alfa Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Eftrenonacog Alfa in 2021
Figure 66. Manufacturing Process Analysis of Eftrenonacog Alfa
Figure 67. Industry Chain Structure of Eftrenonacog Alfa
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets